Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Clinitech Laboratory Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Clinitech Laboratory Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Clinitech Laboratory - Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The C
-
Clinitech Laboratory has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Clinitech Laboratory - Non Applicability Disclosure W.R.T Large Corporate
-
Clinitech Laboratory - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Clinitech Laboratory - Board Meeting Outcome for Outcome Of Board Meeting Held On March 25, 2025 At The Registered Office Of
-
Clinitech Laboratory - Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company To Be Held On Tuesda
-
Clinitech Laboratory - Disclosure Under Regulation 30 Of SEBI (LODR), 2015.
Key fundamentals
Evaluate the intrinsic value of Clinitech Laboratory Ltd stock
| Name | March-24 | March-23 | March-22 | ||
|---|---|---|---|---|---|
| Assets | 4.4113 | 3.4099 | 2.7342 | ||
| Liabilities | 4.4113 | 3.4099 | 2.7342 | ||
| Equity | 1.68 | 1.5 | 1.5 | ||
| Gross Profit | 0.9804 | 1.351 | 1.0665 | ||
| Net Profit | 0.3712 | 0.6131 | 0.5126 | ||
| Cash From Operating Activities | -1.3989 | 1.2475 | 0.9557 | ||
| NPM(%) | 5.79 | 9.65 | 8.02 | ||
| Revenue | 6.403 | 6.3475 | 6.3843 | ||
| Expenses | 5.4226 | 4.9965 | 5.3178 | ||
| ROE(%) | 11.73 | 19.38 | 16.2 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Clinitech Laboratory Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 810.05 | -1.12 | 26.88 | 24.38 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 74.39 | 0.39 | 308.58 | 88.82 | 14.01 | 0.68 |
| Bharat Immunological and Biologicals Corporation Ltd | 25.66 | -5.45 | 0.00 | 184.42 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 698.00 | -1.87 | 0.00 | 83.75 | -687.11 | 0.00 |
Company Info
Our Company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai bearing Registration number 201078. The status of the Company was changed to public limited and the name of our Company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai. Our corporate identification number is U85195MH2010PLC201078.Major Events and Milestones:2010-Incorporation of our Company.2012-Established new Lab at Kalyan2016-NABL Accreditation at Airoli Centre2018-Established new Lab at Thane2021-NABL Accreditation for SARS-COV-2 testing-Signed up agreements for Diagnostic Centre at Kharghar2022-Signed up agreements for Diagnostic Centre at Panvel / Badlapur2023-Converted Company to Limited-Established new Lab at Murbad
Our Company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai bearing Registration number 201078. The status of the Company was changed to public limited and the name of our Company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai. Our corporate identification number is U85195MH2010PLC201078.Major Events and Milestones:2010-Incorporation of our Company.2012-Established new Lab at Kalyan2016-NABL Accreditation at Airoli Centre2018-Established new Lab at Thane2021-NABL Accreditation for SARS-COV-2 testing-Signed up agreements for Diagnostic Centre at Kharghar2022-Signed up agreements for Diagnostic Centre at Panvel / Badlapur2023-Converted Company to Limited-Established new Lab at Murbad
Read More
Parent Organisation
Clinitech Laboratory Ltd.
Founded
19/03/2010
Managing Director
Mr.Jagdish Umakant Nayak
NSE Symbol
FAQ
The current price of Clinitech Laboratory Ltd is
The 52-week high for Clinitech Laboratory Ltd is
The market capitalization of Clinitech Laboratory Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Clinitech Laboratory Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Clinitech Laboratory Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Clinitech Laboratory Ltd shares.
The CEO of Clinitech Laboratory Ltd is Mr.Jagdish Umakant Nayak, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
